A novel method to measure functional status of ErbB2 in breast cancer

被引：0
|
作者：
Kong, Anthony
Leboucher, Pierre
Leek, Russell
Winter, Stuart
Harris, Adrian
Parker, Peter
Larijani, Banafshe
机构：
[1] London Res Inst, Canc Res UK, London, England
[2] Coll France, Lab Physiol Percept & Act, Paris, France
[3] Univ Oxford, Inst Mol Med, Oxford, England
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1952
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Dual targeting of ErbB1 and ErbB2 enhances response to chemotherapy in ErbB2 overexpressing breast cancer cell lines.
    O'Donovan, N.
    Clynes, M.
    Crown, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S105 - S105
  • [32] Analysis of a novel mutation of ERBB2 in cancer of unknown primary
    Harada, Yohei
    Kashiwada, Tomomi
    Sato, Akemi
    Abe, Tomonori
    Nakashima, Chiho
    Sueoka, Eisaburo
    Kimura, Shinya
    Aragane, Naoko
    CANCER SCIENCE, 2018, 109 : 533 - 533
  • [33] ErbB2 assay in breast cancer: Possibly improved clinical information using a quantitative method
    Dittadi, R
    Brazzale, A
    Pappagallo, G
    Salbe, C
    Nascimben, O
    Rosabian, A
    Gion, M
    ANTICANCER RESEARCH, 1997, 17 (2B) : 1245 - 1247
  • [34] PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer
    Ni, Ruoyu
    Mulligan, Anna Marie
    Have, Cherry
    O'Malley, Frances P.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (03): : 316 - 324
  • [35] EGFR and ErbB2 mutation status in Japanese lung cancer patients
    Sasaki, H
    Shimizu, S
    Endo, K
    Takada, M
    Kawahara, M
    Tanaka, H
    Matsumura, A
    Iuchi, K
    Haneda, H
    Suzuki, E
    Kobayashi, Y
    Yano, M
    Fujii, Y
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 180 - 184
  • [36] Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer
    Zito, Christina I.
    Riches, David
    Kolmakova, Julia
    Simons, Jan
    Egholm, Michael
    Stern, David F.
    GENES CHROMOSOMES & CANCER, 2008, 47 (07): : 633 - 638
  • [37] Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy
    Bychkov, Dmitrii
    Linder, Nina
    Tiulpin, Aleksei
    Kuecuekel, Hakan
    Lundin, Mikael
    Nordling, Stig
    Sihto, Harri
    Isola, Jorma
    Lehtimaeki, Tiina
    Kellokumpu-Lehtinen, Pirkko-Liisa
    von Smitten, Karl
    Joensuu, Heikki
    Lundin, Johan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Identification of ErbB2 function in the heart: implication for anti-ErbB2 therapy in breast cancer
    Perry, M-C
    Eichner, L. J.
    Dufour, C. R.
    Muller, W. J.
    Giguere, V.
    CANCER RESEARCH, 2012, 72
  • [39] Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
    Wolfson, Eya
    Goldenberg, Maria
    Solomon, Shira
    Frishberg, Amit
    Pinkas-Kramarski, Ronit
    ONCOTARGET, 2016, 7 (40) : 65320 - 65334
  • [40] Genetic immunization against neu/erbB2 transgenic breast cancer
    Amici, A
    Venanzi, FM
    Concetti, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (04) : 183 - 190
12345